Latest article
The diabetes ‘treatment’ Vertex acquired in its 2019 Semma buyout? It’s headed to the...
The stem cell-derived therapy at the center of Vertex's $ 950 million...
Genomic evaluation reveals mobile reason for kind 1 diabetes
Using a combination of two genomic methods, researchers have shown that pancreatic exocrine cells are involved in type 1 diabetes.
Researchers at the University...